Lormetazepam is a short-acting benzodiazepine primarily utilized in the management of insomnia to assist with both sleep onset and maintenance. This category contains high-quality reference standards for… Read more
Lormetazepam is a short-acting benzodiazepine primarily utilized in the management of insomnia to assist with both sleep onset and maintenance. This category contains high-quality reference standards for Lormetazepam, as well as its essential impurities, including Impurity A, Impurity B, and Impurity C. These compounds are vital for pharmaceutical laboratories conducting rigorous impurity profiling and method validation, ensuring that therapeutic products meet stringent regulatory quality standards. By providing access to the parent API alongside its related degradation products and stable isotope labelled versions, this collection supports precise quantitative analysis in both routine quality control and complex bioanalytical studies. Chemists rely on these characterized reference materials to accurately identify and quantify potential contaminants, ultimately facilitating the development and safety assessment of benzodiazepine-based medications.